Back HCV Prevention

HIV11: Sexually Transmitted HCV Rising among HIV+ Gay Men in Europe, but More Are Getting Treated

Hepatitis C virus (HCV) infection rates continue to rise among HIV positive people in Europe, with the highest incidence among injection drug users and men who have sex with men, researchers reported at the 11th International Congress on Drug Therapy in HIV Infection last month in Glasgow. Another study, however, found that HIV/HCV coinfected people are now more likely to receive hepatitis C treatment.

alt

Read more:

U.S. Agencies Recommend Blunt Suture Needles to Reduce Risk of Viral Hepatitis and HIV

In late May, U.S. agencies concerned with worker health and safety issued a joint advisory recommending that healthcare personnel should use blunt-tip suture needles as an alternative to standard suture needles for stitching muscle and connective tissue, in order to decrease the risk of needle-stick injuries that could transmit blood-borne diseases such as hepatitis B, hepatitis C, and HIV.alt

Read more:

Scientists Find Antibodies that Neutralize Multiple Strains of Hepatitis C Virus

As described in a report published in the April 4, 2012, online edition of Proceedings of the National Academy of Sciences, Erick Giang and Mansun Law from the Scripps Research Institute and colleagues have identified a set of antibodies with activity against 5 different antigenic regions on the E1E2 complex of the hepatitis C virus (HCV) outer envelope.alt

Read more:

Professional Tattooing and Piercing Not Linked to Hepatitis C Risk

While amateur tattoos and other body modifications done in prison or other non-professional settings can carry an increased risk of acquiring hepatitis C virus (HCV), there is no evidence of increased transmission risk for tattoos or piercings done in professional studios, according to a meta-analysis described in the April 15, 2012 issue of Clinical Infectious Diseases.alt

Read more:

Canadian Researchers Make Progress in Quest for Hepatitis C Vaccine

Researchers at the University of Albert say they have discovered a new vaccine candidate that stimulates immune response against all genotypes of hepatitis C virus (HCV). The variability of the virus enables it to elude the immune system and has so far hampered efforts to develop an effective vaccine.alt

Read more: